Deal Note: Crowell & Moring Advises UniPixel on Underwritten Public Offering
Firm News | 1 min read | 05.27.16
Washington, D.C. – May 27, 2016: Uni-Pixel, Inc., a company that develops and markets performance engineered films for the touch screen and flexible electronics markets, today announced the pricing of its underwritten public offering of an aggregate of 5,350,000 newly issued shares of common stock at a price of $1.50 per share. UniPixel expects to receive gross proceeds of $8.03 million, before deducting underwriting discounts and other estimated offering expenses. The underwriters have also been granted a 30-day option to purchase up to 802,500 shares of common stock to cover over-allotments, if any. The net proceeds to the UniPixel from the offering of its shares are expected to be approximately $7.46 million after deduction of underwriting discounts and assuming no exercise of the underwriters' over-allotment option. Subject to customary conditions, the offering is expected to close on June 2, 2016.
Crowell & Moring served as lead legal counsel to UniPixel in this transaction, and the team included Jeffrey C. Selman, Karen Kopel, Joshua Reynolds, and Kelly Howard.
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing